Resource Center

Noble/Aptar Pharma Digital Health Webinar

By Bill Guilliouma | June 4, 2021
Posted in , , ,

Joint Webinar from Noble & Aptar Pharma Discusses How to Improve Patient Adherence and Compliance With Innovative Digital Healthcare Solutions Hear from Adam Shain, Business Development Director, Digital Healthcare, Aptar… Read More »

The Critical Role of Training in The Use Of Nasal Rescue Therapies

By Bill Guilliouma | May 18, 2021
Posted in , , , , , , , , , , , , , , , , ,

Startling statistics have revealed the magnitude of the global opioid epidemic. According to the World Health Organization (WHO), in 2018 about 58 million people worldwide used opioids, and another 35.6… Read More »

Human Factors + Webinar: Regulatory Overview

By Bill Guilliouma | May 17, 2021
Posted in

Part 1 of Noble’s Human Factors + Webinar Series: Regulatory Overview Join Noble’s Joe Reynolds and Joe Masci, along with Human Factors expert Kevin Cluff, in the first of our… Read More »

Noble Further Expands Its Human Factors Expertise with Two New Hires for Newly Created HF-Focused Positions

By Bill Guilliouma | May 13, 2021
Posted in

According to the US FDA, human factors engineering is an essential component of product development for drug delivery and medical devices. The US FDA recommends making it a robust part… Read More »

Noble Launches Human Factors Engineering Services to Support Product Development and US FDA Approval of Medical Devices and Combination Products

By Bill Guilliouma | February 2, 2021
Posted in , , , ,

“Human Factors Plus” (HF+) is a natural extension of Noble’s deep understanding of the patient experience when it comes to self-administering drug therapies ORLANDO, Fla. (February 2, 2021) – Noble,… Read More »

Training Devices & Patient Education Play A Crucial Role in The Self-Injection Drug Delivery Market

By Bill Guilliouma | October 27, 2020
Posted in , , , , , ,

The biopharmaceutical industry has experienced incredible exponential growth in recent decades. Annual revenues have increased from US$4.4 billion (ÂŁ3.4 billion) in 1990 to $275 billion (ÂŁ213 billion) in 2018 (a… Read More »